Expert Review of Anti-Infective Therapy

Article	Citations
Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials	93
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review	78
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a	65
Antiviral drugs for coronavirus disease 2019 (COVID-19): a systematic review with network meta-analysis	64
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin	62
Neonatal ocular prophylaxis in the United States: is it still necessary?	56
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex	51
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis	50
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies	41
Challenges in preserving antibiotic effectiveness: time for a novel approach	39
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future	37
Visceral leishmaniasis elimination in India: progress and the road ahead	37
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria	35
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies	35
The emergence of Japanese encephalitis as a public health concern in New South Wales Australia	34
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines	34
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720	32
Tineas caused by hedgehogs due to Trichophyton erinacei an ascending agent of dermatophytosis	28
Hypoalbuminemia as a predictor of severe dengue: a systematic review and meta-analysis	27
Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges	26
All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies	26
Accuracy of gradient diffusion method for susceptibility testing of dalbavancin and comparators	24
Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’	22
Can inhaled antifungals provide a viable solution for treatment-refractory pulmonary fungal infections?	22
New and emerging roles for inhalational and direct antifungal drug delivery approaches for treatment of invasive fungal infections	22

Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China	21
Identifying predictors of treatment failure with community-acquired pneumonia: an update	20
Reemergence of monkeypox: prevention and management	19
The ongoing challenge of prevention of pertussis in infants: what’s new in 2024?	19
Treatment of vaginitis caused by non-albicans Candida species	19
Iatrogenic factors of Helicobacter pylori eradication failure: lessons from the frontline	18
Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin	18
Advances and controversies in the diagnosis and management of neurocysticercosis: a clinical perspective	17
Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review	17
Diagnostic and clinical management of Candida auris infections in immunocompromised patients	17
Phage- and enzybiotic-coated urinary catheters to prevent recurrent multidrug-resistant bacterial infections	17
Diagnostic and management strategies for chronic hepatitis E infection	16
Understanding host responses to equine encephalitis virus infection: implications for therapeutic development	16
Theranostic nanomaterials for scalp and hair fungal infections: advancing diagnosis and treatment amidst challenges	16
Real-world effectiveness and tolerability of post solid organ transplant patients with CMV switching from valganciclovir treatment to maribavir: analysis using lab-linked claims data in the United Sta	16
Predicting the limit to ceftriaxone’s use in gonorrhea treatment: impending resistance and logistical challenges	15
Infliximab as a potential treatment for COVID-19	15
Correction	14
Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive pulmonary diseases	14
Analysis of bacterial spectrum and construction of a predictive model for postoperative sepsis in patients with upper urinary calculi and positive urinary cultures	14
Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential	14
Healthcare professionals’ understanding and perception of drug-related issues linked to off-label pharmacological medications used for COVID-19	14
Anti-inflammatory and immunomodulatory effects of mesenchymal stem cell therapy on parasitic drug resistance	14
Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases	14
Predictors and patterns of empirical antibiotic therapy and associated outcomes in COVID-19 patients: a retrospective study in a tertiary care facility in South India	13
Nintedanib: a review of the properties, function, and usefulness to minimize COVID-19-induced lung injury	13
Statement of Retraction	13
Selling antibiotics without prescriptions among community pharmacies and drug outlets: a simulated client study from Ghana	13
The serological dilemma: rethinking syphilis treatment evaluation	13
Oteseconazole: a long-awaited diversification of the antifungal arsenal to manage recurrent vulvovaginal candidiasis (RVVC)	13
Low-risk penicillin allergy delabeling: a scoping review of direct oral challenge practice, implementation, and multi-disciplinary approaches	12
Perceptions and preparedness of senior medical students about antimicrobial stewardship programs: are we providing adequate training to future prescribers?	12
How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review	12
The opportunities and challenges of epigenetic approaches to manage herpes simplex infections	12
In vitro and in vivo activity of meropenem+avibactam against MBL-producing carbapenem-resistant Klebsiella pneumoniae	12
Clinical utility of procalcitonin in implementation of procalcitonin-guided antibiotic stewardship in the South-East Asia and India: evidence and consensus-based recommendations	11
Interrupting HIV transmission networks: how can we design and implement timely and effective interventions?	11
Ceftazidime-avibactam and aztreonam combination for Carbapenem-resistant Enterobacterales bloodstream infections with presumed Metallo-β-lactamase production: a systemat	11
Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection	11
Exploring thresholds and interaction effects among antibiotic usage, covariates, and their effect on antibiotic resistance using an extended-spectrum β-Lactamase–producing Klebsiella pneumoniae	11
Diagnosing fungal infections in clinical practice: a narrative review	11
New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae	11
Monoclonal antibodies for the treatment of COVID-19 infection in children	11
How can we tackle the overuse of antibiotics in low- and middle-income countries?	10
Real-world discontinuations due to neuropsychiatric symptoms in people living with HIV treated with second-generation integrase inhibitors: a systematic review	10
Detection of SARS-CoV-2 by antigen ELISA test is highly swayed by viral load and sample storage condition	10
The evolving debate around screening for Chlamydia trachomatis	10
Monotherapy versus combination for the treatment of Stenotrophomonas maltophilia: a multicenter cohort study	10
Investigating forthcoming strategies to tackle deadly superbugs: current status and future vision	10
Interaction of zincite, alpha-terpineol, geranyl acetate, linalool, myrcenol, terpinolene, and thymol with virulence factors of Escherichia coli, Mycobacterium tuberculosis, Pseudomonas	10

Challenges associated with pertussis detection, monitoring, and vaccination in adults	10
An overview of potential combination therapies with ceftriaxone as a treatment for gonorrhoea	10
Gram-positive infections in special populations. Expert view on the role of dalbavancin	9
The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals	9
Tocilizumab for the treatment of COVID-19	9
Nirmatrelvir and ritonavir combination: an antiviral therapy for COVID-19	9
How do we best manage Clostridioides difficle infections in the elderly?	9
Phage therapy: resurrecting a historical solution for the contemporary challenge of rising antibiotic resistance in Latin America	9
New insights into the treatment of acute otitis media	9
Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19: a systematic review and meta-analysis	9
Now that griseofulvin is not available, what to do with tinea capitis treatments?	9
Clinical outcomes, virological efficacy and safety of nitazoxanide in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials	9
Practices, Knowledge, and Attitudes of Nephrologists Towards Prescribing and Monitoring Vancomycin at Dialysis Centers	9
Vitamin D attenuates biofilm-associated infections via immunomodulation and cathelicidin expression: a narrative review	9
Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents	9
Could Herpesviridae be the cause of severe acute hepatitis of unknown origin in children?	9
Evaluation of Namibia’s antiretroviral therapy guidelines’ recommendations for switching from first-line to second-line, using predictors of first-line treatment failure: an exploratory study	9
Clinical outcomes of sofosbuvir-based antivirals in patients with COVID-19: a systematic review and meta-analysis of randomized trials	8
Comparison of clinical outcomes of antibiotics used for Staphylococcus aureus bacteremia in pediatric patients	8
Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients	8
Synergistic effect of eravacycline combined with fluconazole against resistant Candida albicans in vitro and in vivo	8
Systematic Review and Meta-Analysis: Efficacy of Vancomycin Taper and Pulse Regimens in Clostridioides difficile Infection	8
Strengths and caveats of identifying resistance genes from whole genome sequencing data	8
Understanding mechanisms of virulence in MRSA: implications for antivirulence treatment strategies	8
Women trailblazers shaping the global future of antimicrobial stewardship and antimicrobial resistance	8
Ivermectin: a pathway out of the pandemic or another dead end?	8
Efficacy and safety of eravacycline (ERV) in treating infections caused by Gram-negative pathogens: a systematic review and meta-analysis	8
RETRACTED ARTICLE: Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial	8
Update on actinomycetoma treatment: linezolid in the treatment of actinomycetomas due to Nocardia spp and Actinomadura madurae resistant t	8
Artificial intelligence and prescription of antibiotic therapy: present and future	8
Clinical efficacy of probiotics in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials	8
Past, present, and future perspectives on aztreonam and avibactam	8
Assessing sex differential in COVID-19 mortality rate by age and polymerase chain reaction test results: an Iranian multi-center study	8
Metallo-beta-lactamases: mechanisms, treatment challenges, and future prospects	8
Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV	7
Lenacapavir: a twice-yearly treatment for adults with multidrug-resistant HIV infection and limited treatment options	7
A systems thinking approach for antimicrobial stewardship in primary care	7
The prevalence of antimicrobial drug resistance of non-typhoidal Salmonella in human infections in sub-Saharan Africa: a systematic review and meta-analysis	7
Host defense mechanisms against Candida auris	7
Unveiling the potential role of micro/nano biomaterials in the treatment of Helicobacter pylori infection	7
Public knowledge of antibiotics, self-medication, and household disposal practices in Jordan	7
An update on newer antifungals	7
Containment strategies for COVID-19 in India: lessons from the second wave	7
Introduction and spread of NDM-producing Enterobacterales and Acinetobacter baumannii into Middle Eastern countries: a molecular-based hypothesis	7
Risk factors for colistin-resistant, extensively drug-resistant (XDR) and pandrug-resistant (PDR) Acinetobacter baumannii infections: a review	7
Global importance of new treatment strategies to efforts to control hepatitis B virus	7
Effect of tixagevimab/cilgavimab for pre-exposure prophylaxis during the China Omicron outbreak	7
Tracing the recent updates on vaccination approaches and significant adjuvants being developed against HIV	7
An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critical	7
Can probiotics replace antibiotics? Not yet, says the evidence	6
Antimicrobial consumption in patients with COVID-19: a systematic review and meta-analysis	6
HTLV-I associated bronchioloalveolar disorder (HABA): disease concept and differential diagnosis of an unsolved disease entity	6
The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to lose	6
Antibiofilm and antimicrobial activity of curcumin-chitosan nanocomplexes and trimethoprim-sulfamethoxazole onAchromobacter, Burkholderia, andStenotrophomonasisolates	6
Analysis of clinical characteristics and prognostic factors of ARDS caused by community-acquired pneumonia in people with different immune status	6
Rifampicin in periprosthetic joint infections: where do we stand and where are we headed?	6
The war against bacteria, from the past to present and beyond	6
Critical reappraisal of current issues for improving the proper clinical use of the incoming beta-lactam/beta-lactamase inhibitor combinations of tomorrow	6
Non-cancerous complications in HTLV-1 carriers	6
Safety and efficacy of new generation azole antifungals in the management of recalcitrant superficial fungal infections and onychomycosis	6
Mitigation of insufficient hospital workforce and personal protective equipment in the anti-COVID-19 campaign in mainland China	6
Treatment of cryptosporidiosis: nitazoxanide yes, but we can do better	6
High frequency and molecular characterization of ESBL-producing Enterobacteriaceae isolated from wound infections in North Lebanon	6
Brucellosis control methods with an emphasis on vaccination: a systematic review	6
Brincidofovir in the Era of Mpox	6
Wide-spectrum antibiotic prophylaxis guarantees optimal outcomes in drowned donor kidney transplantation	6
Pro-, pre- and synbiotics for the prevention of incidental ventilator-associated pneumonia among critically ill patients: a systematic review and meta-analysis of randomized controlled trials	6
Cross-testing of direct-action antivirals, universal vaccines, or search for host-level antivirals: what will sooner lead to a generic capability to combat the emerging viral pandemics?	6
Langya henipavirus outbreak	5
Economic impact of managing invasive mold disease with isavuconazole compared with liposomal amphotericin B followed by posaconazole in Spain	5
A plain language summary of the safety and effectiveness of isavuconazole for the treatment of serious fungal disease in children with a weakened immune system	5
How do we change our approach to COVID with the changing face of disease?	5
Prevalence of antibiotic resistance in clinical isolates of Mycobacterium kansasii : a systematic review and meta-analysis	5
Letermovir for cytomegalovirus infection in allogeneic hematopoietic stem-cell transplantation: tips and notes for effective use in clinical practice	5
Real-world implementation of dolutegravir plus lamivudine in people living with HIV in Southwest China	5
Candida auris biofilm: a review on model to mechanism conservation	5
Analysis of policies for use of medically important antibiotics in animals in Namibia: implications for antimicrobial stewardship	5
Indian consensus on the management of carbapenem-resistant enterobacterales infection in critically ill patients II (ICONIC II)	5
Evaluation of favipiravir in the treatment of COVID-19 based on the real-world	5
Phage therapy in pediatrics: the way forward for difficult-to-treat infections?	5

Efficacy and appropriateness of novel antibiotics in response to antimicrobial-resistant gram-negative bacteria in patients with sepsis in the ICU	5
Omadacycline in treating community-based infections: a review and expert perspective	5
Management of calcified cysticerci in the brain parenchyma: treating the dead parasite	5
Mechanisms of resistance to cell wall and plasma membrane targeting antifungal drugs in Candida species isolated in Africa	5
Comparative efficacy and safety of antiviral traditional Chinese medicine injections for viral pneumonia: a systematic review and network meta-analysis	5
Gram-negative blood stream infections: prospects and challenges of rapid antimicrobial susceptibility testing	5
Continuous infusion of beta-lactam antibiotics: narrative review of systematic reviews, and implications for outpatient parenteral antibiotic therapy	5
The potential of 4D’s approach in curbing antimicrobial resistance among bacterial pathogens	5
Association of outpatient fluoroquinolone prescribing with the National Medical Products Administration announcements of label changes in China	5
Associations of infection control measures and norovirus outbreak outcomes in healthcare settings: a systematic review and meta-analysis	5
The effects of the pandemic in cases of heart failure	5
Clinical effectiveness of oral antivirals for non-hospitalized adult COVID-19 patients aged 18–60 years	5
Nirmatrelvir/ritonavir: real world drug–drug interaction management experience	4
Evaluation of duration of antibiotic therapy across hospitals in Scotland including the impact of COVID-19 pandemic: a segmented interrupted time series analysis	4
The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants	4
Treatment of carbapenem-resistantPseudomonas aeruginosainfections: a case for cefiderocol	4
Antibiotic resistance in low- and middle-income countries: current practices and its global implications	4
HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective study on safety, efficacy, and immune reconstitution	4
Factors associated with treatment failure, and possible applications of probiotic bacteria in the arsenal againstHelicobacter pylori	4
Letter to the editor: “real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients”	4
Development of antiviral drugs for COVID-19 in 2025: unmet needs and future challenges	4
Assessment of rationality of available fixed dose combinations of antibiotics in India	4
Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) in Canada: treatment update and the role of new IV antimicrobials	4
The efficacy and safety of hydroxychloroquine at different doses and courses for COVID-19 prevention: a systematic review and network meta-analysis	4
The effect of intravenous immunoglobulins on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials	4
Continuous care engagement in clinical practice: perspectives on selected current strategies for people with HIV in the United States	4
COVID-19 and vitamin D (Co-VIVID study): a systematic review and meta-analysis of randomized controlled trials	4
Ursodeoxycholic acid and COVID-19 outcomes: a cohort study and data synthesis of state-of-art evidence	4
False-positivity results in rapid antigen tests for SARS-CoV-2: an umbrella review of meta-analyses and systematic reviews	4
Letter to the Editor: the earliest observation of bla NDM was in Israel	4
Secnidazole: a treatment for trichomoniasis in adolescents and adults	4
The future of non-invasive azole antifungal treatment options for the management of vulvovaginal candidiasis	4
Immunocompromised patients and COVID-19: how do we protect those most at risk?	4
A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials	4
Advantages and limitations of current diagnostic laboratory approaches in syphilis and congenital syphilis	4
Efficacy and safety of vitamin D in tuberculosis patients: a systematic review and meta-analysis	4
Therapeutic potential of 5-aminolevulinic acid and sodium-ferrous citrate for viral insults: relevance to the COVID-19 crisis	4
Virulence factors, antibiotic resistance patterns, and molecular types of clinical isolates of Klebsiella Pneumoniae	4
Artificial intelligence and its application in clinical microbiology	4
Managing sepsis in the era of precision medicine: challenges and opportunities	3
Concerns with current Drug Laws regarding the purchasing antibiotics without a prescription in Pakistan; ways forward to assist the national action plan	3
Personalized care approaches to hepatitis C therapy: recent advances and future directions	3
What is the impact of SARS-CoV-2 infection during pregnancy on child immunity?	3
Clinical management of Kaposi sarcoma herpesvirus-associated diseases: an update on disease manifestations and treatment strategies	3
From Data to Decisions: Leveraging Large, Real-World Databases to Guide Clinical Practice in C. difficile Infections	3
Doxycycline post-exposure prophylaxis as prevention of STIs – the golden bullet?	3
Can the immunological system of the upper respiratory tract, improved by physical exercise, act as a first immunological barrier against SARS-CoV-2?	3
Part 2: Understanding the role of Malassezia spp. in skin disorders: pathogenesis of Malassezia associated skin infections	3
The impacts of the national centralized drug procurement policy on the use of policy-related antibiotic agents: the case of Shaanxi province, China	3
The antifungal pipeline for invasive fungal diseases: what does the future hold?	3
Comparison of dolutegravir+Lamivudine and bictegravir/emtricitabine/tenofovir alafenamide in antiretroviral therapy-naïve patients infected with HIV: preliminary results from clinical practice	3
Antimicrobial management of complex biofilms in diabetic foot ulcers: a microbiological perspective	3
New therapeutic strategies for Mycobacterium abscessus pulmonary diseases – untapping the mycolic acid pathway	3
Therapeutic strategies to address monkeypox	3
Treatment of ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacteria with novel agents: a contemporary, multidisciplinary ESGCIP perspective	3
Statement of Retraction: Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial	3
Adverse effects of antibiotics in children with cancer: are short-course antibiotics for febrile neutropenia part of the solution?	3
Febrile neutropenia management in high-risk neutropenic patients: a narrative review on antibiotic prophylaxis and empirical treatment	3
Carbapenem-resistant Klebsiella pneumoniae : the role of plasmids in emergence, dissemination, and evolution of a major clinical challenge	3
Biosimilars as antivirals: opportunities and challenges	3
Tixagevimab/cilgavimab for prevention and treatment of COVID-19: a review	3
Managing Viral Emerging Infectious Diseases via current Molecular Diagnostics in the Emergency Department: the Tricky Cases	3
Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis	3
Multicenter surveillance of in vitro activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against Enterobacterales, Pseudomonas	3
Could the next disease X be pandemic of virus-induced encephalitis? what should be our first medical response?	3
Current role of ceftobiprole in the treatment of hospital-acquired and community-acquired pneumonia: expert opinion based on literature and real-life experiences	3
Escalation of antimicrobial resistance among MRSA part 1: focus on global spread	3
Pharmacological management of antifungal agents in pulmonary aspergillosis: an updated review	3
Androgen receptor, a possible anti-infective therapy target and a potent immune respondent in SARS-CoV-2 spike binding: a computational approach	3
Meropenem-vaborbactam: a critical positioning for the management of infections by Carbapenem-resistant Enterobacteriaceae	3
Overdose deaths and HIV infections among people who use drugs: shared determinants and integrated responses	3
Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections	3
Prediction and prevention of preterm birth in pregnant women living with HIV on antiretroviral therapy	3